245 related articles for article (PubMed ID: 36306339)
1. ADAMTS13 conformation and immunoprofiles in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura.
Sakai K; Matsumoto M; De Waele L; Dekimpe C; Hamada E; Kubo M; Tersteeg C; De Meyer SF; Vanhoorelbeke K
Blood Adv; 2023 Jan; 7(1):131-140. PubMed ID: 36306339
[TBL] [Abstract][Full Text] [Related]
2. Anti-ADAMTS13 autoantibody profiling in patients with immune-mediated thrombotic thrombocytopenic purpura.
Kangro K; Roose E; Joly BS; Sinkovits G; Falter T; von Auer C; Rossmann H; Reti M; Voorberg J; Prohászka Z; Lämmle B; Coppo P; Veyradier A; De Meyer SF; Männik A; Vanhoorelbeke K
Blood Adv; 2021 Sep; 5(17):3427-3435. PubMed ID: 34495312
[TBL] [Abstract][Full Text] [Related]
3. Open ADAMTS13, induced by antibodies, is a biomarker for subclinical immune-mediated thrombotic thrombocytopenic purpura.
Roose E; Schelpe AS; Tellier E; Sinkovits G; Joly BS; Dekimpe C; Kaplanski G; Le Besnerais M; Mancini I; Falter T; Von Auer C; Feys HB; Reti M; Rossmann H; Vandenbulcke A; Pareyn I; Voorberg J; Greinacher A; Benhamou Y; Deckmyn H; Fijnheer R; Prohászka Z; Peyvandi F; Lämmle B; Coppo P; De Meyer SF; Veyradier A; Vanhoorelbeke K
Blood; 2020 Jul; 136(3):353-361. PubMed ID: 32356859
[TBL] [Abstract][Full Text] [Related]
4. Anti-cysteine/spacer antibodies that open ADAMTS13 are a common feature in iTTP.
De Waele L; Curie A; Kangro K; Tellier E; Kaplanski G; Männik A; Tersteeg C; Joly BS; Coppo P; Veyradier A; De Meyer SF; Roose E; Vanhoorelbeke K
Blood Adv; 2021 Nov; 5(21):4480-4484. PubMed ID: 34559219
[TBL] [Abstract][Full Text] [Related]
5. Generation and validation of small ADAMTS13 fragments for epitope mapping of anti-ADAMTS13 autoantibodies in immune-mediated thrombotic thrombocytopenic purpura.
Kangro K; Roose E; Schelpe AS; Tellier E; Kaplanski G; Voorberg J; De Meyer SF; Männik A; Vanhoorelbeke K
Res Pract Thromb Haemost; 2020 Jul; 4(5):918-930. PubMed ID: 32685903
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) in Japan 2023.
Matsumoto M; Miyakawa Y; Kokame K; Ueda Y; Wada H; Higasa S; Yagi H; Ogawa Y; Sakai K; Miyata T; Morishita E; Fujimura Y;
Int J Hematol; 2023 Nov; 118(5):529-546. PubMed ID: 37689812
[TBL] [Abstract][Full Text] [Related]
7. Immunogenic hotspots in the spacer domain of ADAMTS13 in immune-mediated thrombotic thrombocytopenic purpura.
Velásquez Pereira LC; Roose E; Graça NAG; Sinkovits G; Kangro K; Joly BS; Tellier E; Kaplanski G; Falter T; Von Auer C; Rossmann H; Feys HB; Reti M; Prohászka Z; Lämmle B; Voorberg J; Coppo P; Veyradier A; De Meyer SF; Männik A; Vanhoorelbeke K
J Thromb Haemost; 2021 Feb; 19(2):478-488. PubMed ID: 33171004
[TBL] [Abstract][Full Text] [Related]
8. Anti-ADAMTS13 autoantibodies in immune-mediated thrombotic thrombocytopenic purpura do not hamper ELISA-based quantification of ADAMTS13 antigen.
Dekimpe C; Roose E; Tersteeg C; Joly BS; Dewaele A; Horta S; Pareyn I; Vandenbulcke A; Deckmyn H; Feys HB; Tellier E; Kaplanski G; Scully M; Coppo P; De Meyer SF; Veyradier A; Vanhoorelbeke K
J Thromb Haemost; 2020 Apr; 18(4):985-990. PubMed ID: 31989742
[TBL] [Abstract][Full Text] [Related]
9. Anti-ADAMTS13 Autoantibodies against Cryptic Epitopes in Immune-Mediated Thrombotic Thrombocytopenic Purpura.
Roose E; Vidarsson G; Kangro K; Verhagen OJHM; Mancini I; Desender L; Pareyn I; Vandeputte N; Vandenbulcke A; Vendramin C; Schelpe AS; Voorberg J; Azerad MA; Gilardin L; Scully M; Dierickx D; Deckmyn H; De Meyer SF; Peyvandi F; Vanhoorelbeke K
Thromb Haemost; 2018 Oct; 118(10):1729-1742. PubMed ID: 30235483
[TBL] [Abstract][Full Text] [Related]
10. Overlapping ADAMTS13 peptide binding profiles of DRB1∗08:03 and DRB1∗11:01 suggest a common etiology of immune-mediated thrombotic thrombocytopenic purpura.
Sakai K; Miyadera H; Kubo M; Nakajima F; Matsumoto M
J Thromb Haemost; 2023 Mar; 21(3):616-628. PubMed ID: 36696200
[TBL] [Abstract][Full Text] [Related]
11. Incidence, diagnosis, and outcome of immune-mediated thrombotic thrombocytopenic purpura: A nationwide survey by the Spanish registry of thrombotic thrombocytopenic purpura.
Pascual-Izquierdo C; Del Rio-Garma J; de la Rubia J; Viejo A; Mingot E; Cid J; Solanich X; Fernández-Sojo J; Martín-Sánchez J; Hernández L; García-Gala JM; Alonso N; González V; Oliva A; Gómez-Seguí I; Goterris R; Guerra L; García-Candel F; Fernández-Docampo M; Antelo ML; Salgado-Barreira Á; Salinas R;
J Clin Apher; 2021 Aug; 36(4):563-573. PubMed ID: 33780553
[TBL] [Abstract][Full Text] [Related]
12. Immune-mediated thrombotic thrombocytopenic purpura in patients with and without systemic lupus erythematosus: a retrospective study.
Yue C; Su J; Fan X; Song L; Jiang W; Xia J; Shi T; Zhang X; Li X
Orphanet J Rare Dis; 2020 Aug; 15(1):225. PubMed ID: 32859237
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies enhance ADAMTS-13 clearance in patients with immune thrombotic thrombocytopenic purpura.
Underwood MI; Alwan F; Thomas MR; Scully MA; Crawley JTB
J Thromb Haemost; 2023 Jun; 21(6):1544-1552. PubMed ID: 36813118
[TBL] [Abstract][Full Text] [Related]
14. ADAMTS-13 conformation influences autoimmune recognition in immune thrombotic thrombocytopenic purpura.
Underwood MI; Thomas MR; Scully MA; Crawley JTB
J Thromb Haemost; 2024 Apr; 22(4):1069-1079. PubMed ID: 38160729
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal assessments of plasma ADAMTS13 biomarkers predict recurrence of immune thrombotic thrombocytopenic purpura.
Sui J; Cao W; Halkidis K; Abdelgawwad MS; Kocher NK; Guillory B; Williams LA; Gangaraju R; Marques MB; Zheng XL
Blood Adv; 2019 Dec; 3(24):4177-4186. PubMed ID: 31856267
[TBL] [Abstract][Full Text] [Related]
16. ADAMTS13 Biomarkers in Management of Immune Thrombotic Thrombocytopenic Purpura.
Sui J; Zheng L; Zheng XL
Arch Pathol Lab Med; 2023 Aug; 147(8):974-979. PubMed ID: 36223210
[TBL] [Abstract][Full Text] [Related]
17. Naturally Occurring Anti-Idiotypic Antibodies Portray a Largely Private Repertoire in Immune-Mediated Thrombotic Thrombocytopenic Purpura.
Heeb SR; Schaller M; Kremer Hovinga JA
J Immunol; 2022 Jun; 208(11):2497-2507. PubMed ID: 35589126
[TBL] [Abstract][Full Text] [Related]
18. Generation of anti-idiotypic antibodies to detect anti-spacer antibody idiotopes in acute thrombotic thrombocytopenic purpura patients.
Schelpe AS; Roose E; Joly BS; Pareyn I; Mancini I; Biganzoli M; Deckmyn H; Voorberg J; Fijnheer R; Peyvandi F; De Meyer SF; Coppo P; Veyradier A; Vanhoorelbeke K
Haematologica; 2019 Jun; 104(6):1268-1276. PubMed ID: 30523052
[TBL] [Abstract][Full Text] [Related]
19. Insights into ADAMTS13 structure: impact on thrombotic thrombocytopenic purpura diagnosis and management.
Roose E; Veyradier A; Vanhoorelbeke K
Curr Opin Hematol; 2020 Sep; 27(5):320-326. PubMed ID: 32740038
[TBL] [Abstract][Full Text] [Related]
20. [New developments in treatment modalities of thrombotic thrombocytopenic purpura].
Matsumoto M
Rinsho Ketsueki; 2017; 58(10):2081-2086. PubMed ID: 28978852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
